Back to top

Image: Bigstock

4 Stocks Trading Near 52-Week High That Can Climb Further

Read MoreHide Full Article

Stocks hitting their 52-week high and delivering consistent performance in the past few quarters offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.

Moreover, given the high price, investors often wonder if the stock is overpriced. While the speculations are not baseless, all stocks hitting a 52-week high are not necessarily overpriced.

In fact, investors might lose out on top gainers in an attempt to avoid the steep prices.

Stocks such as MYR Group (MYRG - Free Report) , Henry Schein (HSIC - Free Report) , The Kroger Co. (KR - Free Report) and Coty (COTY - Free Report) are expected to maintain the momentum and keep scaling new highs.  More information on a stock is necessary to understand whether or not there is scope for further upside.

Here we discuss a strategy to find the right stocks. The strategy borrows from the basics of momentum investing. This technique bets on “buy high, sell higher.”

52-Week High: A Good Indicator

Many a time, stocks hitting a 52-week high fail to scale higher despite having potential. This is because investors fear that the stocks are overvalued and expect the price to crash.

In fact, overvaluation is natural for most of these stocks as investors’ focus (or willingness to pay a premium) has helped them reach the level. But that does not always indicate an impending decline. Factors such as robust sales, surging profit levels, earnings growth prospects and strategic acquisitions that encouraged investors to bet on these stocks could keep them motivated if there is no tangible negative. In other words, the momentum might continue.

Also, when a string of positive developments dominates the market, investors find their under-reaction unwarranted, even if there are no company-specific driving forces.

Setting the Right Filters

We ran a screen to zero in on 52-week high stocks (trading near the high level) that hold tremendous upside potential. The screen includes parameters to shortlist stocks with strong earnings growth expectations, sturdy value metrics and price momentum.

Moreover, the screen filters stocks that are relatively undervalued compared to their peers in terms of earnings as well as sales, ensuring the continuation of their rally for some time.

Current Price/52 Week High >= .08

This is the ratio between the current price and the highest price at which the stock has traded in the past 52 weeks. A value greater than 0.08 implies that the stock is trading within 20% of its 52-week high range.

% Change Price – 4 Weeks > 0

It ensures that the stock price has moved north over the past four weeks.

% Change Price – 12 Weeks > 0

This metric guarantees a continued upward price momentum for the stock over the past three months as well.

Price/Sales <= XIndMed

The lower, the better.

P/E using F(1) Estimate <= XIndMed

This metric measures the amount an investor puts into a company to obtain one dollar of earnings. It narrows down the list of stocks to those that are undervalued compared to the industry.

One-Year EPS Growth F(1)/F(0) >= XIndMed

This helps choose stocks that have higher growth rates than the industry. This is a meaningful indicator, as decent earnings growth adds to investor optimism.

Zacks Rank =1 or 2

No screening is complete without the Zacks Rank, which has proved its worth since its inception. It is a fundamental truth that stocks with a Zacks Rank #1 (Strong Buy) or Zacks Rank #2 (Buy) have always managed to brave adversities and beat the market average. You can see the complete list of today’s Zacks #1 Rank stocks here.

Current Price >= 5

This parameter will help screen stocks that are trading at $5 or higher.

Volume – 20 days (shares) >= 100000

The inclusion of this metric ensures that there is a substantial volume of shares, so trading is easier.

Here are our four picks of the 22 stocks that made it through the screen:

MYR Group is implementing targeted strategies to capture new market opportunities in the evolving clean energy landscape while continuing organic and acquisitive expansion. These make it a solid investment option in the utility sector. Last month, its unit MYR Group Construction Canada, Ltd. acquired all issued and outstanding shares of capital stock of Powerline Plus Ltd. and its affiliate (“Powerline Plus Companies”). This acquisition will strengthen MYR Group’s transmission and distribution business as well as expand its geographical reach.

The company currently sports a Zacks Rank of 1. The Zacks Consensus Estimate for MYRG’s 2023 earnings has increased 4.6% to $5.68 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate thrice in the trailing four quarters while missing the same once, the average surprise being 13.17%.

Henry Schein is a leading distributor of healthcare products and services across the globe. Henry Schein’s distribution business boasts a wide global footprint with 61 distribution centers. Apart from North America and Canada, the company has a presence in Australia and New Zealand as well as in emerging nations like China, Brazil, Israel, the Czech Republic and Poland. We believe Henry Schein’s worldwide reach offers it a major competitive advantage over other players in the healthcare distribution industry. Henry Schein’s joint venture with Internet Brands — Henry Schein One — recently announced the integration of AI solutions into Dentrix Ascend. This is a cloud-based practice management software by Henry Schein One. The latest development solidifies the company’s commitment to helping dental practices leverage the benefits of artificial intelligence. The upgrade in the cloud-based solution expands the company’s Technology and Value-added Services business.

The company currently sports a Zacks Rank of 1. The Zacks Consensus Estimate for HSIC’s 2023 earnings has moved up by 0.2% to $5.32 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 2.97%.

Kroger has been undertaking efforts to strengthen its position not only with respect to products but also in terms of the way consumers shop. It has been making investments to enhance product freshness and quality as well as expand digital capabilities. Kroger has been augmenting Our Brands portfolio by launching new products. Recently, Kroger entered into a deal to acquire Albertsons Companies. The tie-up would help strengthen its position in the competitive grocery space. The combined entity would benefit from a loyal customer base and a broader portfolio.

The company currently sports a Zacks Rank of 1. The Zacks Consensus Estimate for KR’s 2023 earnings has remained steady at $4.49 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 9.76%.

Coty has been benefiting from its focus on six strategic pillars that are aimed at sustainable growth. These include stabilizing Consumer Beauty make-up brands and mass fragrances, accelerating luxury fragrances and setting up Coty as a core player in prestige make-up, establishing a skincare portfolio in prestige and mass channels, strengthening e-commerce and Direct-to-Consumer capabilities, growing presence in China via Prestige and certain Consumer Beauty brands, as well as setting Coty as an industry leader in sustainability. Coty made several strategic partnerships to enhance its brand portfolio. Recently, management raised its like-for-like sales view for fiscal 2023.

The company currently has a Zacks Rank of 2. The Zacks Consensus Estimate for COTY’s fiscal 2023 earnings has remained steady at 37 cents per share in the past 30 days. The company surpassed the Zacks Consensus Estimate twice in the trailing four quarters while breaking even twice, the average surprise being 24.17%.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your trial to the Research Wizard today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


The Kroger Co. (KR) - free report >>

Henry Schein, Inc. (HSIC) - free report >>

MYR Group, Inc. (MYRG) - free report >>

Coty (COTY) - free report >>

Published in